UnitedHealth Group (NYSE:UNH) Shares Acquired Rep. Tim Moore

Representative Tim Moore (R-North Carolina) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on August 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on July 21st.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Harley-Davidson (NYSE:HOG) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Verizon Communications (NYSE:VZ) on 7/29/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/29/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Centene (NYSE:CNC) on 7/22/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/21/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/18/2025.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $245.59 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a market cap of $222.78 billion, a P/E ratio of 10.64, a PEG ratio of 1.62 and a beta of 0.43. The business’s 50-day moving average price is $293.86 and its two-hundred day moving average price is $410.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 3.6%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors have recently added to or reduced their stakes in UNH. ZEGA Investments LLC lifted its position in UnitedHealth Group by 5.8% during the 2nd quarter. ZEGA Investments LLC now owns 10,654 shares of the healthcare conglomerate’s stock valued at $3,324,000 after acquiring an additional 584 shares during the period. Prospera Financial Services Inc boosted its position in shares of UnitedHealth Group by 60.9% in the 2nd quarter. Prospera Financial Services Inc now owns 42,066 shares of the healthcare conglomerate’s stock worth $13,129,000 after purchasing an additional 15,920 shares in the last quarter. True Wealth Design LLC increased its position in UnitedHealth Group by 94.7% during the 2nd quarter. True Wealth Design LLC now owns 364 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 177 shares in the last quarter. Disciplined Investors L.L.C. boosted its holdings in UnitedHealth Group by 9.6% in the second quarter. Disciplined Investors L.L.C. now owns 1,387 shares of the healthcare conglomerate’s stock worth $433,000 after acquiring an additional 122 shares in the last quarter. Finally, Bensler LLC increased its holdings in shares of UnitedHealth Group by 142.1% during the second quarter. Bensler LLC now owns 16,813 shares of the healthcare conglomerate’s stock valued at $5,245,000 after acquiring an additional 9,868 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, Director Kristen Gil bought 3,700 shares of the firm’s stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director directly owned 6,033 shares of the company’s stock, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. KeyCorp reduced their price objective on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Oppenheimer dropped their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Finally, TD Cowen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $366.52.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.

Moore served as speaker of the House from 2015 to 2025.

Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.